EUVIMEDObjevte EUVIMED
Crossref

Efficacy And Safety Evaluation Of A Dry Powder Inhaler Containing Salmeterol Xinafoate 25 Mcg/Fluticasone Propionate 250 Mcg In Subjects With Asthma: A Randomized, Open Label, Comparative, Active Controlled, Parallel Groups, And Multi-Centric Study.

The Internet Journal of Asthma, Allergy and Immunology · 2011

DOI: 10.5580/22b1 ↗

At a glance

Journal article in The Internet Journal of Asthma, Allergy and Immunology, 2011.

AbstraktBibliografické údajeCiteRelated studies

Abstract (original language)

Není k dispozici žádný abstrakt.

Cite

APA

(2011). Efficacy And Safety Evaluation Of A Dry Powder Inhaler Containing Salmeterol Xinafoate 25 Mcg/Fluticasone Propionate 250 Mcg In Subjects With Asthma: A Randomized, Open Label, Comparative, Active Controlled, Parallel Groups, And Multi-Centric Study. The Internet Journal of Asthma, Allergy and Immunology. https://doi.org/10.5580/22b1

Vancouver

Efficacy And Safety Evaluation Of A Dry Powder Inhaler Containing Salmeterol Xinafoate 25 Mcg/Fluticasone Propionate 250 Mcg In Subjects With Asthma: A Randomized, Open Label, Comparative, Active Controlled, Parallel Groups, And Multi-Centric Study. The Internet Journal of Asthma, Allergy and Immunology. 2011. doi:10.5580/22b1

BibTeX
@article{euvimed2011,
  title = {Efficacy And Safety Evaluation Of A Dry Powder Inhaler Containing Salmeterol Xinafoate 25 Mcg/Fluticasone Propionate 250 Mcg In Subjects With Asthma: A Randomized, Open Label, Comparative, Active Controlled, Parallel Groups, And Multi-Centric Study},
  journal = {The Internet Journal of Asthma, Allergy and Immunology},
  year = {2011},
  doi = {10.5580/22b1}
}
Start for free →